within Pharmacolibrary.Drugs.ATC.H;

model H05BX02_1
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.72,
    Cl             = 0.01933333333333333,
    adminDuration  = 600,
    adminMass      = 0.004,
    adminCount     = 1,
    Vd             = 0.018,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.008333333333333333,
    Tlag           = 900
  );

  annotation(Documentation(
    info ="<html><body><p>Paricalcitol is a synthetic vitamin D analog used mainly to prevent and treat secondary hyperparathyroidism associated with chronic kidney disease (CKD). It is approved for clinical use and available in both intravenous and oral formulations.</p><h4>Pharmacokinetics</h4><p>Reported pharmacokinetics in healthy adult volunteers following oral administration.</p><h4>References</h4><ol><li><p>Freundlich, M, &amp; Abitbol, CL (2017). Oral paricalcitol: expanding therapeutic options for pediatric chronic kidney disease patients. <i>Pediatric nephrology (Berlin, Germany)</i> 32(7) 1103–1108. DOI:<a href=&quot;https://doi.org/10.1007/s00467-017-3675-7&quot;>10.1007/s00467-017-3675-7</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/28451892/&quot;>https://pubmed.ncbi.nlm.nih.gov/28451892</a></p></li><li><p>Dennis, VC, &amp; Albertson, GL (2006). Doxercalciferol treatment of secondary hyperparathyroidism. <i>The Annals of pharmacotherapy</i> 40(11) 1955–1965. DOI:<a href=&quot;https://doi.org/10.1345/aph.1G523&quot;>10.1345/aph.1G523</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/17062838/&quot;>https://pubmed.ncbi.nlm.nih.gov/17062838</a></p></li><li><p>Webb, NJA, et al., &amp; Dufek, MB (2017). Efficacy and safety of paricalcitol in children with stages 3 to 5 chronic kidney disease. <i>Pediatric nephrology (Berlin, Germany)</i> 32(7) 1221–1232. DOI:<a href=&quot;https://doi.org/10.1007/s00467-017-3579-6&quot;>10.1007/s00467-017-3579-6</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/28332096/&quot;>https://pubmed.ncbi.nlm.nih.gov/28332096</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end H05BX02_1;
